文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Recent insights into contributing factors in the pathogenesis of cirrhotic ascites.

作者信息

Li Zhen, Zhu Junfeng, Ouyang Hao

机构信息

Department of Hepatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Hepatology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Med (Lausanne). 2024 Sep 13;11:1376217. doi: 10.3389/fmed.2024.1376217. eCollection 2024.


DOI:10.3389/fmed.2024.1376217
PMID:39346937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11427383/
Abstract

Cirrhotic ascites refers to the accumulation of fluid in the peritoneal cavity due to severe liver disease and impaired liver function, which leads to poor blood circulation in the body, increased pressure in the hepatic sinus wall, and the exudation of fluid from the plasma into the peritoneal cavity. Cirrhotic ascites is a common complication of cirrhosis and poses a threat to the health and lives of modern people, causing a heavy social burden worldwide. So far, there are no effective treatment methods available to improve the quality and quantity of life for patients and their partners; existing drugs can only alleviate the symptoms of cirrhotic ascites and slow down its progression. This article aims to carefully examine the pathogenesis of cirrhotic ascites by exploring various contributing factors such as portal hypertension, renal dysfunction, inflammation, growth factors, oxidative stress, immunocytes, and gut microbiota. The purpose is to gain better insights and deeper understanding of the mechanisms involved in this condition.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52fa/11427383/ec8fdf5d8ef8/fmed-11-1376217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52fa/11427383/7f7de018aa03/fmed-11-1376217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52fa/11427383/ec8fdf5d8ef8/fmed-11-1376217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52fa/11427383/7f7de018aa03/fmed-11-1376217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52fa/11427383/ec8fdf5d8ef8/fmed-11-1376217-g002.jpg

相似文献

[1]
Recent insights into contributing factors in the pathogenesis of cirrhotic ascites.

Front Med (Lausanne). 2024-9-13

[2]
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.

Liver Int. 2013-9-2

[3]
[Liver cirrhosis: pathogenesis of ascites and disturbance of renal function].

Rev Med Chil. 1992-2

[4]
Current concepts in the management of refractory cirrhotic ascites.

Niger J Med. 2006

[5]
Pathophysiology and a Rational Basis of Therapy.

Dig Dis. 2015

[6]
Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol.

JBI Database System Rev Implement Rep. 2015-1

[7]
Severe Ascites in Common Variable Immunodeficiency.

Cureus. 2022-10-13

[8]
Cirrhotic ascites. Pathophysiology, diagnosis, and management.

Ann Intern Med. 1986-10

[9]
Hyperdynamic circulation of cirrhotic rats: role of substance P and its relationship to nitric oxide.

Scand J Gastroenterol. 1997-8

[10]
Nitric oxide and renal function in cirrhotic patients with ascites: from physiopathology to practice.

Eur J Gastroenterol Hepatol. 2004-6

引用本文的文献

[1]
The Covert Side of Ascites in Cirrhosis: Cellular and Molecular Aspects.

Biomedicines. 2025-3-10

本文引用的文献

[1]
The mitochondrial biliverdin exporter ABCB10 in hepatocytes mitigates neutrophilic inflammation in alcoholic hepatitis.

Redox Biol. 2024-4

[2]
Kidney Dysfunction in the Setting of Liver Failure: Core Curriculum 2024.

Am J Kidney Dis. 2024-3

[3]
Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension.

Int J Mol Sci. 2023-11-27

[4]
The Portal Vein: A Comprehensive Review.

Radiographics. 2023-11

[5]
Liver endothelial cells in NAFLD and transition to NASH and HCC.

Cell Mol Life Sci. 2023-10-5

[6]
5-aminolevulinate and CHIL3/CHI3L1 treatment amid ischemia aids liver metabolism and reduces ischemia-reperfusion injury.

Theranostics. 2023

[7]
Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma.

Int J Mol Sci. 2023-8-30

[8]
Hepatic inflammatory responses in liver fibrosis.

Nat Rev Gastroenterol Hepatol. 2023-10

[9]
Gut microbiota bridges dietary nutrients and host immunity.

Sci China Life Sci. 2023-11

[10]
Age-mediated gut microbiota dysbiosis promotes the loss of dendritic cells tolerance.

Aging Cell. 2023-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索